AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Telmecaid-M25 Tablet ER

Prescription Icon
Prescription Required

Marketer

Medicaid Labs LLP

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (25mg)

Overview Telmecaid-M25 Tablet ER

Telmecaid-M25 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. Consistent blood levels are achieved by taking this medication with food at the same time daily, as directed by your physician. Continue treatment as prescribed; discontinuing, even feeling well, can worsen hypertension, often symptom-free. Lifestyle modifications—regular exercise, weight management, and a healthy diet—further aid blood pressure control. Adhere to your doctor's instructions. Potential side effects include headache, weakness, dizziness, hypotension (possibly with fainting), shortness of breath, nausea, vomiting, stomach pain, fatigue, and elevated potassium. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor of liver or kidney issues before starting treatment, and pregnant or breastfeeding individuals should seek medical advice. Disclose all medications, especially those for hypertension or heart conditions.

Primary Ingredients of Telmecaid-M25 Tablet ER

The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.

Uses of Telmecaid-M25 Tablet ER

Managing Elevated Blood Pressure

Major Benefits of Telmecaid-M25 Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the Telmecaid-M25 Tablet ER whole; avoid chewing, crushing, or fracturing it. Administer this extended-release tablet with a meal.

Common Side effects of Telmecaid-M25 Tablet ER:

  • Headache
  • Weakness
  • Dizziness
  • Cold extremities
  • Slow heart rate
  • Increased potassium level in blood
  • Decreased blood pressure
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Breathlessness
  • Vomiting
  • Abdominal pain

How to use Telmecaid-M25 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Telmecaid-M25 Extended-Release Tablets should be taken with a meal.

How Telmecaid-M25 Tablet ER works:

Telmisartan and Metoprolol Succinate, combined in Telmecaid-M25 Extended-Release tablets, work together to reduce blood pressure.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Telmecaid-M25 Tablet ER is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Telmecaid-M25 tablets present a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Telmecaid-M25 tablets are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Extended-release Telmecaid-M25 tablets can cause drowsiness, blurred vision, and dizziness. Driving is prohibited if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Telmecaid-M25 Extended-Release tablets are considered safe for use in individuals with impaired renal function. No alteration of the Telmecaid-M25 Extended-Release tablet dosage is necessary.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Telmecaid-M25 Extended-Release tablets. Dosage modification of Telmecaid-M25 Extended-Release tablets may be necessary; physician consultation is advised.

What if you forget to take Telmecaid-M25 Tablet ER :

Should you forget a dose of Telmecaid-M25 Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Telmecaid-M25 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Heart

FAQs on Telmecaid-M25 Tablet ER

Yes, Telmecaid-M25 Tablet ER Succinate may cause dizziness, especially when standing up quickly from a lying or sitting position. To minimize this risk, rise slowly from a seated or reclined position.
Improve your health by adopting a healthier lifestyle while taking Telmecaid-M25 Tablet ER Succinate. Quit smoking to lower your risk of heart attack and stroke. Weight loss is recommended if you're overweight or obese. Eat a balanced diet rich in fruits and vegetables. Regular physical activity strengthens your heart and reduces heart attack risk.
Continue taking Telmecaid-M25 Tablet ER as prescribed, even if you feel healthy. Abruptly stopping this medication can cause serious health problems, including heart attack or stroke.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Telmecaid-M25 Tablet ER
77
MRP 89
13% off